Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation
NCT07639255 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330
Last updated 2026-07-01
Summary
This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements associated with improved quality and retention of patients in the screening process. A feedback report is delivered to identify priorities for process improvement.
Conditions
- Lung Cancer Screening
Interventions
- OTHER
-
QUILS System
Implementation initiative involving statewide coalition engagement surveys, interviews, educational outreach, and collaborative activities designed to improve awareness, coordination, policy support, and implementation of equitable and high-quality lung screening programs.
Sponsors & Collaborators
-
Timothy Mullett
lead OTHER
Principal Investigators
-
Timothy W Mullett, MD · University of Kentucky
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-01
- Primary Completion
- 2027-06-01
- Completion
- 2028-06-01
Countries
- United States
Study Locations
More Related Trials
-
Validation of a Multi-gene Test for Lung Cancer Risk
NCT01130285 ·Status: ACTIVE_NOT_RECRUITING
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
NCT00026754 ·Status: COMPLETED
-
Efficacy of Point Of Service Testing in MBC
NCT03983577 ·Status: UNKNOWN ·Phase: NA
-
Improving Care After Inherited Cancer Testing
NCT04763915 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
NCT04902144 ·Status: COMPLETED ·Phase: NA
-
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
NCT03617939 ·Status: RECRUITING
-
Methylated Biomarkers of Smoking as a Selection Tool in Participants for Lung Cancer Screening
NCT07631624 ·Status: RECRUITING ·Phase: NA
-
A Genotype-Phenotype Urothelial Cancer Registry
NCT00902590 ·Status: ACTIVE_NOT_RECRUITING
-
Engaging Diverse Underserved Communities to Bridge the Mammography Divide
NCT01267110 ·Status: COMPLETED ·Phase: NA
-
Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00758173 ·Status: UNKNOWN
-
Biomarkers of Molecular Risk in Smokers
NCT00598143 ·Status: COMPLETED
-
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
NCT00898313 ·Status: RECRUITING
-
Ovarian Screening Study
NCT00267072 ·Status: COMPLETED
-
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
NCT06760507 ·Status: RECRUITING ·Phase: NA
-
Family History Study on Cancer Risk
NCT04145388 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The BARCODE 1 Pilot Study
NCT03158922 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00757614 ·Status: UNKNOWN
-
Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
NCT03319290 ·Status: UNKNOWN
-
Tumor-Derived FGF19
NCT06068257 ·Status: COMPLETED
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NCT00001163 ·Status: ACTIVE_NOT_RECRUITING
-
Community Clinic Model to Improve Early Detection of Breast and Cervical Cancers in Kenya
NCT06572774 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Community Based Approach to Reducing Rural Cancer Disparities, Aim 2
NCT02973022 ·Status: COMPLETED
-
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing
NCT04213326 ·Status: COMPLETED
-
Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection
NCT05585684 ·Status: RECRUITING